Search

A recent study conducted by researchers at Boehringer Ingelheim Animal Health in Lyon, France, evaluated the safety of an oral combination product for dogs called NexGard (R) PLUS. The product is indicated for the prevention of heartworm disease, the treatment and prevention of flea and tick infestations, and the treatment of gastrointestinal nematode infections. The safety of the product was assessed in three studies involving puppies, ABCB1-deficient collie dogs, and dogs infected with adult Dirofilaria immitis. The results showed that NexGard (R) PLUS was safe and did not cause any significant adverse effects. [Extracted from the article]

Keywords for this news article include: Lyon, France, Europe, Animal Health Companies, Biopharmaceutical Companies, Boehringer Ingelheim, Business, Healthcare Biotechnology Companies, Pyrantel, Pyrantel Pamoate, Thiophenes, Boehringer Ingelheim Animal Health. Keywords: Lyon; France; Europe; Animal Health Companies; Biopharmaceutical Companies; Boehringer Ingelheim; Business; Healthcare Biotechnology Companies; Pyrantel; Pyrantel Pamoate; Thiophenes EN Lyon France Europe Animal Health Companies Biopharmaceutical Companies Boehringer Ingelheim Business Healthcare Biotechnology Companies Pyrantel Pyrantel Pamoate Thiophenes 59 59 1 09/11/23 20230911 NES 230911 2023 SEP 11 (NewsRx) -- By a News Reporter-Staff News Editor at Veterinary Week -- Researchers detail new data in Biotechnology. [Extracted from the article]